---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058874"
form_type: "8-K"
ticker: "MIST"
cik: "0001408443"
company_name: "Milestone Pharmaceuticals Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:29:44.846696+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve 2019 EIP amendment, increase share pool by 4M; directors elected

## Summary
- Proposal to amend 2019 EIP to remove evergreen provision and add 4,000,000 shares approved (8.04M for, 4.74M against, 14.9M broker non-votes).
- All eight director nominees elected: Joseph Oliveto, Stuart Duty, Seth Fischer, Lisa Giles, Joseph Papa, Andrew Saik, Michael Tomsicek, Robert Wills.
- Ratification of PwC as auditor passed with 28.1M for, 284k against, 159k abstentions.
- Non-binding advisory vote on executive compensation (9.2M for, 3.6M against) and triennial frequency (12.3M for 1-year) passed.

## SEC filing metadata
- accession: 0001104659-25-058874
- form_type: 8-K
- ticker: MIST
- cik: 0001408443
- company_name: Milestone Pharmaceuticals Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1408443/000110465925058874/0001104659-25-058874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1408443/000110465925058874/tm2517690d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058874
- JSON: https://secwatch.observer/filing/0001104659-25-058874.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.